Zobrazeno 1 - 10 of 14 pro vyhledávání: '"Elżbieta Rdzanek"'
1
Akademický článek
Reimbursement decision-making system in Poland systematically compared to other countries
Autor: Aneta Mela, Elżbieta Rdzanek, Janusz Jaroszyński, Marzena Furtak-Niczyporuk, Mirosław Jabłoński, Maciej Niewada
Publikováno v: Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Our objective was to analyze and compare systematically and structurally reimbursement systems in Poland and other countries.Methods: The systems were selected based on recommendations issued by the Polish Agency for Health Technology A
Externí odkaz: https://doaj.org/article/850e45adae784396b24d91d79cf8b626
Zobrazit plný text záznamu
2
Akademický článek
Economic Costs of Cardiovascular Diseases in Poland Estimates for 2015–2017 Years
Autor: Aneta Mela, Elżbieta Rdzanek, Łukasz A. Poniatowski, Janusz Jaroszyński, Marzena Furtak-Niczyporuk, Małgorzata Gałązka-Sobotka, Dominik Olejniczak, Maciej Niewada, Anna Staniszewska
Publikováno v: Frontiers in Pharmacology, Vol 11 (2020)
BackgroundCardiovascular diseases are associated with growing public and private expenditure on healthcare regardless geographic region. Therefore, it is necessary to accurately estimate the overall societal costs—both direct and indirect expenses
Externí odkaz: https://doaj.org/article/b877eff27ed64aba9f35dbf50d21e680
Zobrazit plný text záznamu
4
The impact of changing the funding model for genetic diagnostics and improved access to personalized medicine in oncology
Autor: Aneta Mela, Elżbieta Rdzanek, Andrzej Tysarowski, Magdalena Sakowicz, Janusz Jaroszyński, Marzena Furtak-Niczyporuk, Grzegorz Żurek, Łukasz A. Poniatowski, Beata Jagielska
In January 2017, a new funding model for diagnostic genetic testing in cancer was introduced in Poland. The aim of this study was to assess the impact of changing the funding model for genetic diagnosis in oncology on improving access to personalized
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b17ee0e87456c56cee79a140fc026ffb
Zobrazit plný text záznamu
5
Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis
Autor: Justyna Pawęska, Olga Adamowicz-Sidor, Michał Jakubczyk, Maciej Niewada, Elżbieta Rdzanek, Marcin Czech
Publikováno v: BMC Endocrine Disorders
Background Diabetes mellitus (DM) leads to multiple complications, including severe hypoglycaemia events (SHEs). SHEs can impact a patient’s quality of life and compliance and may directly result in additional costs to the health care system. The a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e5871a37cbd1c08f61bfdcaeb8faf41
https://doi.org/10.1186/s12902-015-0052-z
Zobrazit plný text záznamu
6
Economic resources consumption structure in severe hypoglycemia episodes: a systematic review and meta-analysis
Autor: Michał Jakubczyk, Elżbieta Rdzanek, Maciej Niewada, Marcin Czech
Publikováno v: Expert review of pharmacoeconomicsoutcomes research. 15(5)
Diabetes mellitus (DM) is associated with severe hypoglycemia events (SHEs) that vary in severity and resource consumption. Here we perform a systematic review in Medline of studies evaluating SHE-related health resource use. Eligible studies investi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d703a580a2aeef65d502556aaa73646
https://pubmed.ncbi.nlm.nih.gov/26289736
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje